Related Experiment Video
Updated: Feb 20, 2026

Noninvasive, High-throughput Determination of Sleep Duration in Rodents
Published on: April 18, 2018
PER3 VNTR polymorphism in Multiple Sclerosis: A new insight to impact of sleep disturbances in MS
Masoud Golalipour1, Zahra Maleki2, Touraj Farazmandfar1
1Medical Cellular and Molecular Research center, Golestan University of Medical Sciences, Gorgan, Iran.
Background:
Multiple Sclerosis (MS) is a degenerative disease of central nervous system caused by an immune response against the myelin. About half of MS patients suffers from sleep disturbances. The circadian clock genes such as PER3 controls circadian rhythm and sleep. Due to the role of PER3 in sleep disturbances and regulation of immune response, it is possible that PER3 dysregulation increase risk of MS disease.
Methods:
Study groups included 160 MS patients and 160 healthy volunteers. PER3 VNTR polymorphism was evaluated by PCR method. The genotypic and allelic distribution analyzed by chi square test.
Results:
There was a significant association between genotype PER34/4, and 4-repeat allele with MS disease (p = 0.014 and p < 0.001 respectively). The association analysis of PER3 VNTR polymorphism with gender status among MS group, and MS onset showed that there was a significant correlation between PER34/4 genotype with female gender and early onset of MS disease (p = 0.033 and p = 0.028 respectively).
Conclusion:
Our data suggest that, PER34/4 genotype may accelerate the course of disease in MS susceptible individuals.
Insights
The PER3 4/4 genotype is linked to an increased risk and earlier onset of Multiple Sclerosis (MS). This finding suggests PER3 gene variants may influence MS disease progression.
Area of Science:
- Neuroimmunology
- Genetics
- Sleep Medicine
Background:
- Multiple Sclerosis (MS) is a central nervous system autoimmune disease affecting myelin.
- Sleep disturbances are common in MS patients, impacting quality of life.
- Circadian rhythm genes, like PER3, influence both sleep and immune responses.
Purpose of the Study:
- To investigate the association between the PER3 VNTR polymorphism and Multiple Sclerosis (MS).
- To explore the potential role of PER3 gene variants in MS susceptibility and disease characteristics.
Main Methods:
- Genotyping of the PER3 VNTR polymorphism in 160 MS patients and 160 healthy controls using PCR.
- Statistical analysis of genotypic and allelic distributions using the chi-square test.
Main Results:
- A significant association was found between the PER3 4/4 genotype and the 4-repeat allele with MS.
- The PER3 4/4 genotype correlated significantly with female gender and earlier MS onset.
- p-values indicated strong statistical significance for these associations (p=0.014, p<0.001, p=0.033, p=0.028).
Conclusions:
- The PER3 4/4 genotype may be a risk factor for developing MS.
- This genotype might accelerate disease progression in individuals susceptible to MS.
- PER3 gene variants warrant further investigation in the context of MS pathogenesis and clinical course.
More Related Videos
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
Related Concept Videos
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
REM Sleep Behavior Disorder
RBD is significantly associated with...
Narcolepsy
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...